Long‐Term Follow‐Up of Moderately Hypercholesterolemic Hypertensive Patients Following Randomization to Pravastatin vs Usual Care: The Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (<scp>ALLHAT</scp>‐<scp>LLT</scp>)

Karen L. Margolis(HealthPartners), Jeff D. Williamson(University Memory and Aging Center), Thomas J. Hartney, Jerry O. Ciocon(Cleveland Clinic Florida), John Stokes, Paula T. Einhorn(Tulane University), Barry R. Davis(National Institutes of Health), David E. Mathis(Augusta University), Lara M. Simpson(The University of Texas Health Science Center at Houston), Jeffrey L. Probstfield(National Heart Lung and Blood Institute), Aloysius B. Cuyjet(Nassau University Medical Center), Charles Baimbridge, David Gordon(Universidade Federal de Ouro Preto), Jordan L. Holtzman(Veterans Health Administration), Charles E. Ford(The University of Texas Health Science Center at Houston), L. Julian Haywood, Suzanne Oparil(University of Alabama at Birmingham), Thomas Wiegmann(Veterans Health Administration), Richard A. Dart(Marshfield Clinic)
Journal of Clinical Hypertension
June 10, 2013
Cited by 27


Related Papers